132 related articles for article (PubMed ID: 30984585)
1. Oral Antifungal Therapy: Emerging Culprits of Cutaneous Adverse Drug Reactions.
Chaudhary RG; Rathod SP; Jagati A; Zankat D; Brar AK; Mahadevia B
Indian Dermatol Online J; 2019; 10(2):125-130. PubMed ID: 30984585
[TBL] [Abstract][Full Text] [Related]
2. Oral antifungal-exacerbated inflammatory flare-up reactions of dermatomycosis : case reports and review of the literature.
Nikkels AF; Nikkels-Tassoudji N; Piérard GE
Am J Clin Dermatol; 2006; 7(5):327-31. PubMed ID: 17007544
[TBL] [Abstract][Full Text] [Related]
3. A Study of Cutaneous Adverse Drug Reactions at a Tertiary Care Center in Andhra Pradesh, India.
Ashifha S; Vijayashree J; Vudayana K; Chintada D; P P; G P; Unnikrishnan P
Cureus; 2023 Apr; 15(4):e37596. PubMed ID: 37197134
[TBL] [Abstract][Full Text] [Related]
4. A Clinico-Epidemiological Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Centre of Eastern India.
Sinha S; Kar C; Das S; Dutta A; De A
Indian J Dermatol; 2024; 69(1):106. PubMed ID: 38572036
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous Adverse Drug Reactions in a Tertiary Care Teaching Hospital in India: An Intensive Monitoring Study.
Thakkar S; Patel TK; Vahora R; Bhabhor P; Patel R
Indian J Dermatol; 2017; 62(6):618-625. PubMed ID: 29263536
[TBL] [Abstract][Full Text] [Related]
6. Clinico-mycological study of dermatophytic infections and their sensitivity to antifungal drugs in a tertiary care center.
Mahajan S; Tilak R; Kaushal SK; Mishra RN; Pandey SS
Indian J Dermatol Venereol Leprol; 2017; 83(4):436-440. PubMed ID: 28540871
[TBL] [Abstract][Full Text] [Related]
7. Morphological Pattern of Cutaneous Adverse Drug Reactions due to Antiepileptic Drugs in Eastern India.
Singh PK; Kumar MK; Kumar D; Kumar P
J Clin Diagn Res; 2015 Jan; 9(1):WC01-3. PubMed ID: 25738068
[TBL] [Abstract][Full Text] [Related]
8. Nevirapine: Most Common Cause of Cutaneous Adverse Drug Reactions in an Outpatient Department of a Tertiary Care Hospital.
Pawar MP; Pore SM; Pradhan SN; Burute SR; Bhoi UY; Ramanand SJ
J Clin Diagn Res; 2015 Nov; 9(11):FC17-20. PubMed ID: 26672558
[TBL] [Abstract][Full Text] [Related]
9. Etiological prevalence and antifungal sensitivity patterns of dermatophytosis in India - A multicentric study.
Tahiliani S; Saraswat A; Lahiri AK; Shah A; Hawelia D; Shah GK; Girdhar M; Rao PN; Raghav PA; Agarwal P; Kharkar RD; Gupta RP; Udare S; Hegde S; Haldar S
Indian J Dermatol Venereol Leprol; 2021; 87(6):800-806. PubMed ID: 34160163
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous adverse drug reactions in a tertiary care teaching hospital: A North Indian perspective.
Nandha R; Gupta A; Hashmi A
Int J Appl Basic Med Res; 2011 Jan; 1(1):50-3. PubMed ID: 23776774
[TBL] [Abstract][Full Text] [Related]
11. A study of cutaneous adverse drug reactions at a tertiary center in Jammu, India.
Sharma R; Dogra D; Dogra N
Indian Dermatol Online J; 2015; 6(3):168-71. PubMed ID: 26009710
[TBL] [Abstract][Full Text] [Related]
12. Clinical Profile and Comparison of Causality Assessment Tools in Cutaneous Adverse Drug Reactions.
Beniwal R; Gupta LK; Khare AK; Mittal A; Mehta S; Balai M
Indian Dermatol Online J; 2019; 10(1):27-33. PubMed ID: 30775295
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous adverse drug reactions in Indian population: A systematic review.
Patel TK; Thakkar SH; Sharma D
Indian Dermatol Online J; 2014 Dec; 5(Suppl 2):S76-86. PubMed ID: 25593813
[TBL] [Abstract][Full Text] [Related]
14. A Retrospective Study of Drug Induced Cutaneous Adverse Reactions (CADR) in Patients Attending Tertiary Care Hospital.
Doshi K; Yegnanarayan R; Gokhale N
Curr Drug Saf; 2016 Jul; ():. PubMed ID: 27457767
[TBL] [Abstract][Full Text] [Related]
15. Risk of serious skin disorders among users of oral antifungals: a population-based study.
Castellsague J; García-Rodríguez LA; Duque A; Pérez S
BMC Dermatol; 2002 Nov; 2():14. PubMed ID: 12456265
[TBL] [Abstract][Full Text] [Related]
16. Incidence of cutaneous adverse drug reactions among medical inpatients of Sultanah Aminah Hospital Johor Bahru.
Latha S; Choon SE
Med J Malaysia; 2017 Jun; 72(3):151-156. PubMed ID: 28733562
[TBL] [Abstract][Full Text] [Related]
17. An Epidemiological and Clinical Analysis of Cutaneous Adverse Drug Reactions Seen in a Tertiary Care Outpatient Clinic in Cairo, Egypt.
El-Nabarawy EA; Elmasry MF; El Lawindi MI; Tarek YA
Acta Dermatovenerol Croat; 2018 Oct; 26(3):233-242. PubMed ID: 30390725
[TBL] [Abstract][Full Text] [Related]
18. A Study of Cutaneous Adverse Drug Reactions and their Association with Autoimmune Diseases at a Tertiary Centre in South-West Rajasthan, India.
Rana S; Gupta K; Agarwal N; Ahamed ANM
Indian J Dermatol; 2021; 66(4):445. PubMed ID: 34759420
[TBL] [Abstract][Full Text] [Related]
19. Retrospective Analysis of Pattern of Cutaneous Adverse Drug Reactions in Tertiary Hospital of Pauri Garhwal.
Dimri D; Raina RS; Thapliyal S; Thawani V
J Clin Diagn Res; 2016 May; 10(5):FC01-6. PubMed ID: 27437240
[TBL] [Abstract][Full Text] [Related]
20. Clinical profile of cutaneous adverse drug reactions: a retrospective study of 1883 hospitalized patients from 2007 to 2016 in Shanghai, China.
Yang F; Chen Z; Chen SA; Zhu Q; Wang L; Xiong H; Fu H; Luo X
Eur J Dermatol; 2020 Feb; 30(1):24-31. PubMed ID: 32031529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
